Table 4.
Logistic regression for pathologic complete response by subtype and proliferation, GeparSixto, and CIN70 scores.
| Subtype and scores | Odds Ratio | 95% Confidence interval | p-value |
|---|---|---|---|
| PAM50 subtype | |||
| Nonbasal vs. basal | 0.77 | (0.52,1.12) | 0.17 |
| BRCA Case vs. Matched Control | 1.17 | (0.80,1.71) | 0.41 |
| Nonbasal vs. basal*BRCA Case vs. Matched Control | 1.16 | (0.80,1.70) | 0.44 |
| Proliferation score | |||
| Proliferation score | 3.14 | (1.36,7.23) | 0.007 |
| BRCA Case vs. Matched Control | 1.13 | (0.84,1.54) | 0.41 |
| Proliferation*BRCA Case vs. Matched Control | 0.56 | (0.24,1.30) | 0.18 |
| GeparSixto score | |||
| GeparSixto score | 1.67 | (1.15,2.44) | 0.007 |
| BRCA Case vs. Matched Control | 1.10 | (0.48,2.49) | 0.82 |
| GeparSixto*BRCA Case vs. Matched Control | 0.99 | (0.68,1.45) | 0.97 |
| CIN70 score | |||
| CIN70 score | 2.15 | (1.29,3.58) | 0.003 |
| BRCA Case vs. Matched Control | 4.66 | (0.65,33.55) | 0.13 |
| CIN70*BRCA Case vs. Matched Control | 0.67 | (0.40,1.12) | 0.13 |